Raymond James & Associates’s Oaktree Specialty Lending OCSL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$683K Sell
41,853
-2,120
-5% -$36.3K ﹤0.01% 2921
2024
Q2
$827K Sell
43,973
-5,811
-12% -$112K ﹤0.01% 2755
2024
Q1
$979K Sell
49,784
-3,280
-6% -$66.3K ﹤0.01% 2607
2023
Q4
$1.08M Buy
53,064
+5,896
+13% +$116K ﹤0.01% 2468
2023
Q3
$949K Sell
47,168
-8,153
-15% -$163K ﹤0.01% 2491
2023
Q2
$1.07M Buy
55,321
+10,258
+23% +$193K ﹤0.01% 2425
2023
Q1
$846K Buy
45,063
+4,788
+12% +$95.4K ﹤0.01% 2556
2022
Q4
$830K Buy
40,275
+753
+2% +$15.2K ﹤0.01% 2541
2022
Q3
$711K Sell
39,522
-2,367
-6% -$48.2K ﹤0.01% 2603
2022
Q2
$823K Sell
41,889
-5,879
-12% -$124K ﹤0.01% 2579
2022
Q1
$1.06M Sell
47,768
-152,313
-76% -$3.41M ﹤0.01% 2556
2021
Q4
$4.48M Sell
200,081
-113,406
-36% -$2.51M ﹤0.01% 1631
2021
Q3
$6.64M Buy
313,487
+2,663
+0.9% +$56.3K 0.01% 1312
2021
Q2
$6.24M Sell
310,824
-13,768
-4% -$276K 0.01% 1347
2021
Q1
$6.04M Sell
324,592
-17,489
-5% -$315K 0.01% 1308
2020
Q4
$5.72M Sell
342,081
-26,008
-7% -$404K 0.01% 1265
2020
Q3
$5.34M Buy
368,089
+1,546
+0.4% +$22.1K 0.01% 1185
2020
Q2
$4.92M Buy
366,543
+58,284
+19% +$725K 0.01% 1194
2020
Q1
$3M Sell
308,259
-10,390
-3% -$152K ﹤0.01% 1338
2019
Q4
$5.22M Sell
318,649
-4,031
-1% -$63.5K 0.01% 1213
2019
Q3
$5.01M Sell
322,680
-160
-0% -$2.52K 0.01% 1224
2019
Q2
$5.25M Buy
322,840
+514
+0.2% +$8.31K 0.01% 1189
2019
Q1
$5.01M Buy
322,326
+21,927
+7% +$327K 0.01% 1190
2018
Q4
$3.81M Sell
300,399
-302,320
-50% -$4.13M 0.01% 1234
2018
Q3
$8.97M Buy
602,719
+207,827
+53% +$3.07M 0.01% 888
2018
Q2
$5.66M Buy
394,892
+57,752
+17% +$804K 0.01% 1125
2018
Q1
$4.26M Buy
337,140
+130,534
+63% +$1.81M 0.01% 1235
2017
Q4
$3.03M Buy
206,606
+181,433
+721% +$2.91M 0.01% 1419
2017
Q3
$413K Sell
25,173
-1,680
-6% -$26.8K ﹤0.01% 2598
2017
Q2
$392K Sell
26,853
-13,414
-33% -$171K ﹤0.01% 2562
2017
Q1
$558K Sell
40,267
-30,261
-43% -$451K ﹤0.01% 2310
2016
Q4
$1.14M Sell
70,528
-143,342
-67% -$2.39M ﹤0.01% 1850
2016
Q3
$3.73M Buy
213,870
+194,753
+1,019% +$3.34M 0.01% 1100
2016
Q2
$278K Buy
19,117
+4,431
+30% +$67.8K ﹤0.01% 2456
2016
Q1
$221K Sell
14,686
-5,275
-26% -$82.6K ﹤0.01% 2518
2015
Q4
$382K Sell
19,961
-4,466
-18% -$82.5K ﹤0.01% 2101
2015
Q3
$452K Sell
24,427
-7,424
-23% -$143K ﹤0.01% 1968
2015
Q2
$626K Sell
31,851
-9,986
-24% -$209K ﹤0.01% 1979
2015
Q1
$916K Sell
41,837
-17,769
-30% -$399K ﹤0.01% 1710
2014
Q4
$1.43M Sell
59,606
-37,340
-39% -$965K 0.01% 1346
2014
Q3
$2.67M Sell
96,946
-20,954
-18% -$612K 0.02% 943
2014
Q2
$3.48M Sell
117,900
-6,219
-5% -$175K 0.02% 795
2014
Q1
$3.52M Sell
124,119
-1,733
-1% -$49.4K 0.02% 725
2013
Q4
$3.49M Sell
125,852
-35,403
-22% -$1.05M 0.03% 676
2013
Q3
$4.97M Sell
161,255
-7,958
-5% -$253K 0.04% 472
2013
Q2
$5.3M Buy
+169,213
New +$5.4M 0.05% 405

Other funds holding OCSL

Raymond James & Associates's OCSL Position: Q3 2024 in Review

Raymond James & Associates reduced its Oaktree Specialty Lending (OCSL) stake by 4.8% in Q3 2024, selling an estimated $36.3K and leaving 41,853 shares worth $683K. The position accounts for ﹤0.01% of the portfolio, ranked #2921.

Raymond James & Associates first reported a position in OCSL in Q2 2013 and has held it in 46 quarters since. The position peaked at $8.97M in Q3 2018. 195 funds tracked by Wall St. Rank hold OCSL as of Q3 2024.

  • Raymond James & Associates held 41,853 shares of Oaktree Specialty Lending worth $683K as of Q3 2024.
  • Raymond James & Associates sold 2,120 Oaktree Specialty Lending shares in Q3 2024, an estimated $36.3K.
  • Oaktree Specialty Lending made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2921 holding.
  • Raymond James & Associates first reported a position in Oaktree Specialty Lending in Q2 2013 and has held it in 46 quarters since.
  • Raymond James & Associates's Oaktree Specialty Lending position peaked at $8.97M in Q3 2018.
  • 195 funds tracked by Wall St. Rank held Oaktree Specialty Lending as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.